royal dsm nv on tuesday reaffirmed that sales and adjusted earnings rose in the first three months of 2022 after restating figures to reflect the sale of its material businesses the dutch nutrition health and bioscience company said sales for the first quarter on a continuing basis rose to 201 billion euros 213 billion up from eur173 billion at the same time a year prior the company had previously reported first quarter sales rose 18 to eur259 billion adjusted earnings before interest taxes depreciation and amortization rose to eur367 million from eur333 million it said it had previously reported a 10 rise to eur487 million dsm had said on april 20 that it would sell its protectivematerials business to avient corp for eur144 billion with the transaction expected to complete in the second half of this year on may 31 lanxess ag said it would join with privateequity firm advent international corp to buy dsms engineeringmaterials business for around eur37 billion the deal is expected to close in the first half of 2023